The global market for Brucellosis Vaccines was valued at US$ 11.8 million in the year 2024 and is projected to reach a revised size of US$ 15.2 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Brucellosis Vaccines Market

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Brucellosis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucellosis Vaccines.

The Brucellosis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brucellosis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Brucellosis Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Brucellosis Vaccines Market Report

Report Metric	Details
Report Name	Brucellosis Vaccines Market
Accounted market size in year	US$ 11.8 million
Forecasted market size in 2031	US$ 15.2 million
CAGR	3.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	S19 Vaccine RB51 Vaccine Strain
Segment by Application	Cattle Sheep Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, Vetal Company, CZ Veterinaria, SYVA Laboratorios, Indian Immunologicals, Qilu, Tecnovax, Hester Biosciences, Zoetis, Onderstepoort Biological, Instituto Rosenbusch, Ceva Sante Animale, Calier & Biologicos Laverlam, Biovet
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Brucellosis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Brucellosis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Brucellosis Vaccines Market growing?

Ans: The Brucellosis Vaccines Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Brucellosis Vaccines Market size in 2031?

Ans: The Brucellosis Vaccines Market size in 2031 will be US$ 15.2 million.

What is the market share of major companies in Brucellosis Vaccines Market?

Ans: Global top four manufacturers hold a share above 35%.

What is the Brucellosis Vaccines Market share by region?

Ans: China is the largest market, with a share about 30%.

Who are the main players in the Brucellosis Vaccines Market report?

Ans: The main players in the Brucellosis Vaccines Market are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, Vetal Company, CZ Veterinaria, SYVA Laboratorios, Indian Immunologicals, Qilu, Tecnovax, Hester Biosciences, Zoetis, Onderstepoort Biological, Instituto Rosenbusch, Ceva Sante Animale, Calier & Biologicos Laverlam, Biovet

What are the Application segmentation covered in the Brucellosis Vaccines Market report?

Ans: The Applications covered in the Brucellosis Vaccines Market report are Cattle, Sheep, Others

What are the Type segmentation covered in the Brucellosis Vaccines Market report?

Ans: The Types covered in the Brucellosis Vaccines Market report are S19 Vaccine, RB51 Vaccine Strain

1 Brucellosis Vaccines Market Overview

1.1 Product Definition

1.2 Brucellosis Vaccines by Type

1.2.1 Global Brucellosis Vaccines Market Value Comparison by Type (2024 VS 2031)

1.2.2 S19 Vaccine

1.2.3 RB51 Vaccine Strain

1.3 Brucellosis Vaccines by Application

1.3.1 Global Brucellosis Vaccines Market Value by Application (2024 VS 2031)

1.3.2 Cattle

1.3.3 Sheep

1.3.4 Others

1.4 Global Brucellosis Vaccines Market Size Estimates and Forecasts

1.4.1 Global Brucellosis Vaccines Revenue 2020-2031

1.4.2 Global Brucellosis Vaccines Sales 2020-2031

1.4.3 Global Brucellosis Vaccines Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Brucellosis Vaccines Market Competition by Manufacturers

2.1 Global Brucellosis Vaccines Sales Market Share by Manufacturers (2020-2025)

2.2 Global Brucellosis Vaccines Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Brucellosis Vaccines Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Brucellosis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Brucellosis Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Brucellosis Vaccines, Product Type & Application

2.7 Global Key Manufacturers of Brucellosis Vaccines, Date of Enter into This Industry

2.8 Global Brucellosis Vaccines Market Competitive Situation and Trends

2.8.1 Global Brucellosis Vaccines Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Brucellosis Vaccines Players Market Share by Revenue

2.8.3 Global Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Brucellosis Vaccines Market Scenario by Region

3.1 Global Brucellosis Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Brucellosis Vaccines Sales by Region: 2020-2031

3.2.1 Global Brucellosis Vaccines Sales by Region: 2020-2025

3.2.2 Global Brucellosis Vaccines Sales by Region: 2026-2031

3.3 Global Brucellosis Vaccines Revenue by Region: 2020-2031

3.3.1 Global Brucellosis Vaccines Revenue by Region: 2020-2025

3.3.2 Global Brucellosis Vaccines Revenue by Region: 2026-2031

3.4 North America Brucellosis Vaccines Market Facts & Figures by Country

3.4.1 North America Brucellosis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Brucellosis Vaccines Sales by Country (2020-2031)

3.4.3 North America Brucellosis Vaccines Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Brucellosis Vaccines Market Facts & Figures by Country

3.5.1 Europe Brucellosis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Brucellosis Vaccines Sales by Country (2020-2031)

3.5.3 Europe Brucellosis Vaccines Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Brucellosis Vaccines Market Facts & Figures by Region

3.6.1 Asia Pacific Brucellosis Vaccines Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Brucellosis Vaccines Sales by Region (2020-2031)

3.6.3 Asia Pacific Brucellosis Vaccines Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Brucellosis Vaccines Market Facts & Figures by Country

3.7.1 Latin America Brucellosis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Brucellosis Vaccines Sales by Country (2020-2031)

3.7.3 Latin America Brucellosis Vaccines Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Brucellosis Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Brucellosis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Brucellosis Vaccines Sales by Country (2020-2031)

3.8.3 Middle East and Africa Brucellosis Vaccines Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Brucellosis Vaccines Sales by Type (2020-2031)

4.1.1 Global Brucellosis Vaccines Sales by Type (2020-2025)

4.1.2 Global Brucellosis Vaccines Sales by Type (2026-2031)

4.1.3 Global Brucellosis Vaccines Sales Market Share by Type (2020-2031)

4.2 Global Brucellosis Vaccines Revenue by Type (2020-2031)

4.2.1 Global Brucellosis Vaccines Revenue by Type (2020-2025)

4.2.2 Global Brucellosis Vaccines Revenue by Type (2026-2031)

4.2.3 Global Brucellosis Vaccines Revenue Market Share by Type (2020-2031)

4.3 Global Brucellosis Vaccines Price by Type (2020-2031)

5 Segment by Application

5.1 Global Brucellosis Vaccines Sales by Application (2020-2031)

5.1.1 Global Brucellosis Vaccines Sales by Application (2020-2025)

5.1.2 Global Brucellosis Vaccines Sales by Application (2026-2031)

5.1.3 Global Brucellosis Vaccines Sales Market Share by Application (2020-2031)

5.2 Global Brucellosis Vaccines Revenue by Application (2020-2031)

5.2.1 Global Brucellosis Vaccines Revenue by Application (2020-2025)

5.2.2 Global Brucellosis Vaccines Revenue by Application (2026-2031)

5.2.3 Global Brucellosis Vaccines Revenue Market Share by Application (2020-2031)

5.3 Global Brucellosis Vaccines Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Jinyu

6.1.1 Jinyu Company Information

6.1.2 Jinyu Description and Business Overview

6.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Jinyu Brucellosis Vaccines Product Portfolio

6.1.5 Jinyu Recent Developments/Updates

6.2 Colorado Serum

6.2.1 Colorado Serum Company Information

6.2.2 Colorado Serum Description and Business Overview

6.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Colorado Serum Brucellosis Vaccines Product Portfolio

6.2.5 Colorado Serum Recent Developments/Updates

6.3 Boehringer Ingelheim

6.3.1 Boehringer Ingelheim Company Information

6.3.2 Boehringer Ingelheim Description and Business Overview

6.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio

6.3.5 Boehringer Ingelheim Recent Developments/Updates

6.4 Biogenesis-Bago

6.4.1 Biogenesis-Bago Company Information

6.4.2 Biogenesis-Bago Description and Business Overview

6.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Biogenesis-Bago Brucellosis Vaccines Product Portfolio

6.4.5 Biogenesis-Bago Recent Developments/Updates

6.5 Vetal Company

6.5.1 Vetal Company Company Information

6.5.2 Vetal Company Description and Business Overview

6.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Vetal Company Brucellosis Vaccines Product Portfolio

6.5.5 Vetal Company Recent Developments/Updates

6.6 CZ Veterinaria

6.6.1 CZ Veterinaria Company Information

6.6.2 CZ Veterinaria Description and Business Overview

6.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.6.4 CZ Veterinaria Brucellosis Vaccines Product Portfolio

6.6.5 CZ Veterinaria Recent Developments/Updates

6.7 SYVA Laboratorios

6.7.1 SYVA Laboratorios Company Information

6.7.2 SYVA Laboratorios Description and Business Overview

6.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.7.4 SYVA Laboratorios Brucellosis Vaccines Product Portfolio

6.7.5 SYVA Laboratorios Recent Developments/Updates

6.8 Indian Immunologicals

6.8.1 Indian Immunologicals Company Information

6.8.2 Indian Immunologicals Description and Business Overview

6.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Indian Immunologicals Brucellosis Vaccines Product Portfolio

6.8.5 Indian Immunologicals Recent Developments/Updates

6.9 Qilu

6.9.1 Qilu Company Information

6.9.2 Qilu Description and Business Overview

6.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Qilu Brucellosis Vaccines Product Portfolio

6.9.5 Qilu Recent Developments/Updates

6.10 Tecnovax

6.10.1 Tecnovax Company Information

6.10.2 Tecnovax Description and Business Overview

6.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Tecnovax Brucellosis Vaccines Product Portfolio

6.10.5 Tecnovax Recent Developments/Updates

6.11 Hester Biosciences

6.11.1 Hester Biosciences Company Information

6.11.2 Hester Biosciences Description and Business Overview

6.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Hester Biosciences Brucellosis Vaccines Product Portfolio

6.11.5 Hester Biosciences Recent Developments/Updates

6.12 Zoetis

6.12.1 Zoetis Company Information

6.12.2 Zoetis Description and Business Overview

6.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Zoetis Brucellosis Vaccines Product Portfolio

6.12.5 Zoetis Recent Developments/Updates

6.13 Onderstepoort Biological

6.13.1 Onderstepoort Biological Company Information

6.13.2 Onderstepoort Biological Description and Business Overview

6.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Onderstepoort Biological Brucellosis Vaccines Product Portfolio

6.13.5 Onderstepoort Biological Recent Developments/Updates

6.14 Instituto Rosenbusch

6.14.1 Instituto Rosenbusch Company Information

6.14.2 Instituto Rosenbusch Description and Business Overview

6.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio

6.14.5 Instituto Rosenbusch Recent Developments/Updates

6.15 Ceva Sante Animale

6.15.1 Ceva Sante Animale Company Information

6.15.2 Ceva Sante Animale Description and Business Overview

6.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Ceva Sante Animale Brucellosis Vaccines Product Portfolio

6.15.5 Ceva Sante Animale Recent Developments/Updates

6.16 Calier & Biologicos Laverlam

6.16.1 Calier & Biologicos Laverlam Company Information

6.16.2 Calier & Biologicos Laverlam Description and Business Overview

6.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio

6.16.5 Calier & Biologicos Laverlam Recent Developments/Updates

6.17 Biovet

6.17.1 Biovet Company Information

6.17.2 Biovet Description and Business Overview

6.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Biovet Brucellosis Vaccines Product Portfolio

6.17.5 Biovet Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Brucellosis Vaccines Industry Chain Analysis

7.2 Brucellosis Vaccines Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Brucellosis Vaccines Production Mode & Process Analysis

7.4 Brucellosis Vaccines Sales and Marketing

7.4.1 Brucellosis Vaccines Sales Channels

7.4.2 Brucellosis Vaccines Distributors

7.5 Brucellosis Vaccines Customer Analysis

8 Brucellosis Vaccines Market Dynamics

8.1 Brucellosis Vaccines Industry Trends

8.2 Brucellosis Vaccines Market Drivers

8.3 Brucellosis Vaccines Market Challenges

8.4 Brucellosis Vaccines Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Indian Immunologicals

Onderstepoort Biological

Instituto Rosenbusch

Ceva Sante Animale

Calier & Biologicos Laverlam

BIOVET

Boehringer Ingelheim

List of Tables

Table 1. Global Brucellosis Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Brucellosis Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Brucellosis Vaccines Market Competitive Situation by Manufacturers in 2024

Table 4. Global Brucellosis Vaccines Sales (M Doses) of Key Manufacturers (2020-2025)

Table 5. Global Brucellosis Vaccines Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Brucellosis Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Brucellosis Vaccines Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Brucellosis Vaccines Average Price (USD/K Doses) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Brucellosis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Brucellosis Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Brucellosis Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Brucellosis Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Brucellosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Vaccines as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Brucellosis Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Brucellosis Vaccines Sales by Region (2020-2025) & (M Doses)

Table 18. Global Brucellosis Vaccines Sales Market Share by Region (2020-2025)

Table 19. Global Brucellosis Vaccines Sales by Region (2026-2031) & (M Doses)

Table 20. Global Brucellosis Vaccines Sales Market Share by Region (2026-2031)

Table 21. Global Brucellosis Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Brucellosis Vaccines Revenue Market Share by Region (2020-2025)

Table 23. Global Brucellosis Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Brucellosis Vaccines Revenue Market Share by Region (2026-2031)

Table 25. North America Brucellosis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Brucellosis Vaccines Sales by Country (2020-2025) & (M Doses)

Table 27. North America Brucellosis Vaccines Sales by Country (2026-2031) & (M Doses)

Table 28. North America Brucellosis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Brucellosis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Brucellosis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Brucellosis Vaccines Sales by Country (2020-2025) & (M Doses)

Table 32. Europe Brucellosis Vaccines Sales by Country (2026-2031) & (M Doses)

Table 33. Europe Brucellosis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Brucellosis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Brucellosis Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Brucellosis Vaccines Sales by Region (2020-2025) & (M Doses)

Table 37. Asia Pacific Brucellosis Vaccines Sales by Region (2026-2031) & (M Doses)

Table 38. Asia Pacific Brucellosis Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Brucellosis Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Brucellosis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Brucellosis Vaccines Sales by Country (2020-2025) & (M Doses)

Table 42. Latin America Brucellosis Vaccines Sales by Country (2026-2031) & (M Doses)

Table 43. Latin America Brucellosis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Brucellosis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Brucellosis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Brucellosis Vaccines Sales by Country (2020-2025) & (M Doses)

Table 47. Middle East and Africa Brucellosis Vaccines Sales by Country (2026-2031) & (M Doses)

Table 48. Middle East and Africa Brucellosis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Brucellosis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Brucellosis Vaccines Sales (M Doses) by Type (2020-2025)

Table 51. Global Brucellosis Vaccines Sales (M Doses) by Type (2026-2031)

Table 52. Global Brucellosis Vaccines Sales Market Share by Type (2020-2025)

Table 53. Global Brucellosis Vaccines Sales Market Share by Type (2026-2031)

Table 54. Global Brucellosis Vaccines Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Brucellosis Vaccines Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Brucellosis Vaccines Revenue Market Share by Type (2020-2025)

Table 57. Global Brucellosis Vaccines Revenue Market Share by Type (2026-2031)

Table 58. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2020-2025)

Table 59. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2026-2031)

Table 60. Global Brucellosis Vaccines Sales (M Doses) by Application (2020-2025)

Table 61. Global Brucellosis Vaccines Sales (M Doses) by Application (2026-2031)

Table 62. Global Brucellosis Vaccines Sales Market Share by Application (2020-2025)

Table 63. Global Brucellosis Vaccines Sales Market Share by Application (2026-2031)

Table 64. Global Brucellosis Vaccines Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Brucellosis Vaccines Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Brucellosis Vaccines Revenue Market Share by Application (2020-2025)

Table 67. Global Brucellosis Vaccines Revenue Market Share by Application (2026-2031)

Table 68. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2020-2025)

Table 69. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2026-2031)

Table 70. Jinyu Company Information

Table 71. Jinyu Description and Business Overview

Table 72. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 73. Jinyu Brucellosis Vaccines Product

Table 74. Jinyu Recent Developments/Updates

Table 75. Colorado Serum Company Information

Table 76. Colorado Serum Description and Business Overview

Table 77. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 78. Colorado Serum Brucellosis Vaccines Product

Table 79. Colorado Serum Recent Developments/Updates

Table 80. Boehringer Ingelheim Company Information

Table 81. Boehringer Ingelheim Description and Business Overview

Table 82. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 83. Boehringer Ingelheim Brucellosis Vaccines Product

Table 84. Boehringer Ingelheim Recent Developments/Updates

Table 85. Biogenesis-Bago Company Information

Table 86. Biogenesis-Bago Description and Business Overview

Table 87. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 88. Biogenesis-Bago Brucellosis Vaccines Product

Table 89. Biogenesis-Bago Recent Developments/Updates

Table 90. Vetal Company Company Information

Table 91. Vetal Company Description and Business Overview

Table 92. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 93. Vetal Company Brucellosis Vaccines Product

Table 94. Vetal Company Recent Developments/Updates

Table 95. CZ Veterinaria Company Information

Table 96. CZ Veterinaria Description and Business Overview

Table 97. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 98. CZ Veterinaria Brucellosis Vaccines Product

Table 99. CZ Veterinaria Recent Developments/Updates

Table 100. SYVA Laboratorios Company Information

Table 101. SYVA Laboratorios Description and Business Overview

Table 102. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 103. SYVA Laboratorios Brucellosis Vaccines Product

Table 104. SYVA Laboratorios Recent Developments/Updates

Table 105. Indian Immunologicals Company Information

Table 106. Indian Immunologicals Description and Business Overview

Table 107. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 108. Indian Immunologicals Brucellosis Vaccines Product

Table 109. Indian Immunologicals Recent Developments/Updates

Table 110. Qilu Company Information

Table 111. Qilu Description and Business Overview

Table 112. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 113. Qilu Brucellosis Vaccines Product

Table 114. Qilu Recent Developments/Updates

Table 115. Tecnovax Company Information

Table 116. Tecnovax Description and Business Overview

Table 117. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 118. Tecnovax Brucellosis Vaccines Product

Table 119. Tecnovax Recent Developments/Updates

Table 120. Hester Biosciences Company Information

Table 121. Hester Biosciences Description and Business Overview

Table 122. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 123. Hester Biosciences Brucellosis Vaccines Product

Table 124. Hester Biosciences Recent Developments/Updates

Table 125. Zoetis Company Information

Table 126. Zoetis Description and Business Overview

Table 127. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 128. Zoetis Brucellosis Vaccines Product

Table 129. Zoetis Recent Developments/Updates

Table 130. Onderstepoort Biological Company Information

Table 131. Onderstepoort Biological Description and Business Overview

Table 132. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 133. Onderstepoort Biological Brucellosis Vaccines Product

Table 134. Onderstepoort Biological Recent Developments/Updates

Table 135. Instituto Rosenbusch Company Information

Table 136. Instituto Rosenbusch Description and Business Overview

Table 137. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 138. Instituto Rosenbusch Brucellosis Vaccines Product

Table 139. Instituto Rosenbusch Recent Developments/Updates

Table 140. Ceva Sante Animale Company Information

Table 141. Ceva Sante Animale Description and Business Overview

Table 142. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 143. Ceva Sante Animale Brucellosis Vaccines Product

Table 144. Ceva Sante Animale Recent Developments/Updates

Table 145. Calier & Biologicos Laverlam Company Information

Table 146. Calier & Biologicos Laverlam Description and Business Overview

Table 147. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 148. Calier & Biologicos Laverlam Brucellosis Vaccines Product

Table 149. Calier & Biologicos Laverlam Recent Developments/Updates

Table 150. Biovet Company Information

Table 151. Biovet Description and Business Overview

Table 152. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)

Table 153. Biovet Brucellosis Vaccines Product

Table 154. Biovet Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Brucellosis Vaccines Distributors List

Table 158. Brucellosis Vaccines Customers List

Table 159. Brucellosis Vaccines Market Trends

Table 160. Brucellosis Vaccines Market Drivers

Table 161. Brucellosis Vaccines Market Challenges

Table 162. Brucellosis Vaccines Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Brucellosis Vaccines

Figure 2. Global Brucellosis Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Brucellosis Vaccines Market Share by Type: 2024 & 2031

Figure 4. S19 Vaccine Product Picture

Figure 5. RB51 Vaccine Strain Product Picture

Figure 6. Global Brucellosis Vaccines Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Brucellosis Vaccines Market Share by Application: 2024 & 2031

Figure 8. Cattle

Figure 9. Sheep

Figure 10. Others

Figure 11. Global Brucellosis Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Brucellosis Vaccines Market Size (2020-2031) & (US$ Million)

Figure 13. Global Brucellosis Vaccines Sales (2020-2031) & (M Doses)

Figure 14. Global Brucellosis Vaccines Average Price (USD/K Doses) & (2020-2031)

Figure 15. Brucellosis Vaccines Report Years Considered

Figure 16. Brucellosis Vaccines Sales Share by Manufacturers in 2024

Figure 17. Global Brucellosis Vaccines Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Brucellosis Vaccines Players: Market Share by Revenue in Brucellosis Vaccines in 2024

Figure 19. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Brucellosis Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Brucellosis Vaccines Sales Market Share by Country (2020-2031)

Figure 22. North America Brucellosis Vaccines Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Brucellosis Vaccines Sales Market Share by Country (2020-2031)

Figure 26. Europe Brucellosis Vaccines Revenue Market Share by Country (2020-2031)

Figure 27. Germany Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Brucellosis Vaccines Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Brucellosis Vaccines Revenue Market Share by Region (2020-2031)

Figure 34. China Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Brucellosis Vaccines Sales Market Share by Country (2020-2031)

Figure 44. Latin America Brucellosis Vaccines Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Brucellosis Vaccines Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Brucellosis Vaccines Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Brucellosis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Brucellosis Vaccines by Type (2020-2031)

Figure 54. Global Revenue Market Share of Brucellosis Vaccines by Type (2020-2031)

Figure 55. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2020-2031)

Figure 56. Global Sales Market Share of Brucellosis Vaccines by Application (2020-2031)

Figure 57. Global Revenue Market Share of Brucellosis Vaccines by Application (2020-2031)

Figure 58. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2020-2031)

Figure 59. Brucellosis Vaccines Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global GPCR Assay Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6F12199

Fri Feb 07 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Beta-amyloid Peptide Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13J15230

Fri Feb 07 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Pharmaceutical Pregelatinized Starch Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39B12865

Fri Feb 07 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Buffer Concentrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27L15161

Fri Feb 07 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions